·
10 Min Read

New FDA warning label for Ozempic and Wegovy—plus how and where to get a free COVID vaccine [Podcast]

The AMA Update covers a range of health care topics affecting the lives of physicians and patients. Learn more about where to get a free COVID vaccine.

series
Infectious Diseases
AMA Update Podcast
·
5 Min Read

Top news stories from AMA Morning Rounds®: Week of Sept. 25, 2023

In the news: Recommendation on RSV vaccine for pregnant people, new insights on long COVID, warning added to Ozempic label and more.

Publications & Newsletters
·
7 Min Read

Sept. 22, 2023: National Advocacy Update

AMA urges that telehealth prescribing benefits be protected and more in the latest National Advocacy Update.

Advocacy Update
·
4 Min Read

AMA finds competition decline among drug middlemen

AMA releases updated analysis of competition and vertical integration in commercial PBM markets

Press Releases
Hand of a patient on IV drip receiving a saline solution
·
5 Min Read

Reforms needed to alleviate persistent drug shortages

Federal regulators and Congress need to act now to eliminate persistent drug shortages that threaten patient health and well-being.

series
Leadership
Leadership Viewpoints
Prescription pill bottle
·
12 Min Read

What doctors wish patients knew about anti-obesity medication

Over 40% of Americans have obesity and biological realities make weight loss hard to sustain. Learn more with two obesity medicine physicians.

series
Chronic Diseases
What Doctors Wish Patients Knew™
Person holding a bottle of nutritional supplement capsules
·
8 Min Read

Questions patients may have about weight-loss drugs

The rise in popularity of Wegovy, Ozempic and other anti-obesity medications, has led to more questions among patients with obesity or type 2 diabetes.

Behavioral Health
·
4 Min Read

Top news stories from AMA Morning Rounds®: Week of May 29, 2023

In the news: Eligible Americans lose Medicaid coverage, impact of exercise on brain health, FDA issues warning on off-brand semaglutide and more.

Publications & Newsletters
·
5 Min Read

Top news stories from AMA Morning Rounds®: Week of May 22, 2023

In the news: Benefits of semaglutide, surgeon general warns of social media risks, implants help paralyzed man walk, key long COVID symptoms identified and more.

Publications & Newsletters